−9.66INR
−246.92 MINR
525.34 MINR
About KREBS BIOCHEMICALS & INDUSTRIE
Sector
CEO
Jitendra Shah
Headquarters
Hyderabad
Website
Employees (FY)
210
Founded
1991
ISIN
INE268B01013
FIGI
BBG000DC0GS2
Krebs Biochemicals & Industries Ltd. engages in the manufacture and sale of pharmaceutical ingredients and intermediates. Its products include Androstenedione, Lovastatin, and Simvastatin. The company was founded by Ravindranath Tagore Ravi on December 2, 1991 and is headquartered in Hyderabad, India.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of KREBSBIO is 71.74 INR — it has increased by 3.52% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange KREBS BIOCHEMICALS & INDUSTRIE stocks are traded under the ticker KREBSBIO.
Yes, you can track KREBS BIOCHEMICALS & INDUSTRIE financials in yearly and quarterly reports right on TradingView.
Like other stocks, KREBSBIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KREBS BIOCHEMICALS & INDUSTRIE stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 210.00 employees. See our rating of the largest employees — is KREBS BIOCHEMICALS & INDUSTRIE on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KREBS BIOCHEMICALS & INDUSTRIE EBITDA is −102.35 M INR, and current EBITDA margin is −29.28%. See more stats in KREBS BIOCHEMICALS & INDUSTRIE financial statements.